EBV-Associated Lymphoproliferative Disorders
1 clinical trials · Condition
◉ Watch EBV-Associated Lymphoproliferative Disorders
| Record | Firm | Date |
|---|---|---|
| Application of PD-1 Inhibitors, Tenofovir, Chidamide, and Lenalidomide in Relapsed/Refractory EBV-associated Lymphoproliferative Disorders. (NCT07133763) | The Affiliated Hospital of Xuzhou Medical University | 2025-09-01 |
Track EBV-Associated Lymphoproliferative Disorders automatically
Every clearance here is in the API, with alerts when new ones post.